Chih-Jou Su

4-Indolyl-N-hydroxyphenylacrylamides as potent HDAC class I and IIB inhibitors in vitro and in vivo.

S. Pan, Samir Mehndiratta, Ruei-Shian Wang, 2017, European journal of medicinal chemistry.

1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC.

S. Pan, Han-Li Huang, Chih-Jou Su, 2018, European journal of medicinal chemistry.

2-(Phenylsulfonyl)quinoline N-hydroxyacrylamides as potent anticancer agents inhibiting histone deacetylase.

Chia-Ron Yang, Samir Mehndiratta, Han-Li Huang, 2016, European journal of medicinal chemistry.

Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats

Shui-Tein Chen, S. Pan, Han-Li Huang, 2019, Journal of clinical medicine.

Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease.

S. Pan, Chih-Jou Su, Wei-Jan Huang, 2020, European journal of medicinal chemistry.

Identification and analysis of a selective DYRK1A inhibitor.

J. Hsieh, Chia-Ron Yang, S. Pan, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Urolithin A exhibits a neuroprotective effect against Alzheimer’s disease by inhibiting DYRK1A activity

S. Pan, T. Hwang, Chih-Jou Su, 2023, Journal of food and drug analysis.